Last reviewed · How we verify
GENEVAX IL-12-4532 — Competitive Intelligence Brief
phase 1
Biologic
Live · refreshed every 30 min
Target snapshot
GENEVAX IL-12-4532 (GENEVAX IL-12-4532) — University of Pennsylvania.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| GENEVAX IL-12-4532 TARGET | GENEVAX IL-12-4532 | University of Pennsylvania | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- GENEVAX IL-12-4532 CI watch — RSS
- GENEVAX IL-12-4532 CI watch — Atom
- GENEVAX IL-12-4532 CI watch — JSON
- GENEVAX IL-12-4532 alone — RSS
Cite this brief
Drug Landscape (2026). GENEVAX IL-12-4532 — Competitive Intelligence Brief. https://druglandscape.com/ci/genevax-il-12-4532. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab